Mind Mend Psilocybin Microdosing

Discover Mind Mend Psilocybin Microdosing Products

Mind Mend Psilocybin Microdosing-products
Mind Mend’s Shroom Gummies

Mind Mend psilocybin microdosing products are dedicated to helping people improve their everyday life. The Vancouver-based company acknowledges that pharmaceuticals generally fail us. They do not often address the root causes of our issues (rather, they treat the symptoms). They frequently come with very serious side effects or trigger dependence and tolerance to the medication, requiring more, and more frequent, doses. And often, their help is temporal – once you stop taking them, the problem comes back. Contrast this with the impact of various plant medicines, without the addiction, material side effects, and with longer-lasting results that impact the very source of the problem. The choice should be clear!

We work with BC farms to ensure that we deliver products of incredible quality. We never allow the use of any pesticides or GMO’s. And we deliver to you a wide range of products, including tasty gummies, capsules and more. We also make it easy to find the dose that’s right for you. We deliver across Canada, straight to your door – what could be easier than that!?

Frshminds had the opportunity to interview Matt, one of the founders of Mind Mend, about the company and some of his opinions on the current psychedelic landscape.

Can you tell us a bit about the company? How did it start? Who are the founders?

Mind Mend was created by my business partner and me, who live in Vancouver, BC. We were fed up with the current mental health approach and wanted to be a part of the solution.

What got you interested in psilocybin, specifically bringing psilocybin-based products to market?

We’ve both had profound experiences with psilocybin and other plant medicines. Psilocybin is still inaccessible to most Canadians, and by creating Mind Mend, we believe we could change that. The sheer amount of anecdotal and clinical evidence surfacing proves that this medicine should be available to the masses.

Can you tell us a bit about your manufacturing process? What are your manufacturing practices? How do you handle product testing/purity?

All of our products are made locally, and we have to visit the harvest site to ensure that they are all following health and safety guidelines. We only want to work with the best growers as we believe quality counts. We would never sell any products we wouldn’t personally digest. Our tinctures and gummies are all lab-tested to ensure there are precise dosing to eliminate unwanted experiences.How do you see psychedelic medicine and therapy evolving in the future? Do you see it going more of the pharmaceutical route or natural health product route?

Mind Mend Psilocybin Microdosing Products

We believe medical will lead the way as it should. They are the people needing it most, and it will start with psilocybin. There are many different psychedelic medicines, which is just the tip of the iceberg. We are super excited about the other applications, especially for addiction, mood disorders, and depression. Although it will be mainly pharmaceutical, we believe a niche for recreational will demand a broader legalization use case.

Being pioneers in this space, what have been the biggest challenges you’ve faced in bringing your product to market?

One issue for us has been trying to keep a low profile with friends and family. Although we are very proud of what we do, we have to use caution to navigate this space. Education is also a huge obstacle. The government has done an excellent job in stigmatizing plants like psilocybin mushrooms, just like cannabis, so it’s on us to educate people about the benefits and help them get over their initial fear.

Be sure to visit Mind Mend for more information or view their product reviews on Frshminds, and if you are considering trying psilocybin for mental well-being, reach out to a psychedelic integration therapist.

Share Frshminds Content With Your Network

About the Author

Passionate about studying the psychedelic/mystical experience from a neuropsychological lens, Emily is a member of MAPS Canada Research Committee and graduated with an Honours BSc in Cognitive Neuropsychology from York University.  She currently leads a team of RAS with a randomized, double-blind, placebo-controlled clinical trial investigating microdosing psilocybin for persistent depressive disorder.

Earn points.
Unlock rewards.

Earn points to unlock rewards by completing your Frshminds user profile and writing reviews.
Share Your Experience
and start earning today


Leave a Reply

Sign In


Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.